Literature DB >> 35581458

Alexander et al.: Longer-Term Effects of SGLT2Is.

Huaxi Zou1, Baiquan Qiu1, Jichun Liu2.   

Abstract

Entities:  

Year:  2022        PMID： 35581458      PMCID： PMC9411498          DOI： 10.1007/s11606-022-07655-6

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  5 in total

1.  Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.

Authors:  Jenny E Blau; Sri Harsha Tella; Simeon I Taylor; Kristina I Rother
Journal:  Diabetes Metab Res Rev       Date:  2017-09-29       Impact factor: 4.876

2.  Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis.

Authors:  Jason T Alexander; Erin M Staab; Wen Wan; Melissa Franco; Alexandra Knitter; M Reza Skandari; Shari Bolen; Nisa M Maruthur; Elbert S Huang; Louis H Philipson; Aaron N Winn; Celeste C Thomas; Meltem Zeytinoglu; Valerie G Press; Elizabeth L Tung; Kathryn Gunter; Brittany Bindon; Sanjay Jumani; Neda Laiteerapong
Journal:  J Gen Intern Med       Date:  2021-11-30       Impact factor: 6.473

Review 3.  Euglycemic diabetic ketoacidosis: A missed diagnosis.

Authors:  Prashant Nasa; Sandeep Chaudhary; Pavan Kumar Shrivastava; Aanchal Singh
Journal:  World J Diabetes       Date:  2021-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.